INTRODUCTION
Study Objectives: After nasal continuous positive airway pressure (nCPAP) treatment, several symptoms such as hypersomnolence, daytime fatigue, and impaired concentration improve in patients with obstructive sleep apnea-hypopnea syndrome (OSAHS). A variability of perception of pretreatment sleepiness (response-shift phenomenon) experienced in OSAHS patients before and after nCPAP treatment may reflect informative shifts in an individual's internal standards, in values and priorities, or in the conceptualization of perceived sleepiness. The objective of this study is to determine whether there is a response shift in perceptions of pretreatment sleepiness before and after nCPAP treatment in patients with OSAHS. We investigated the response shift in Epworth Sleepiness Scale scores before and after nCPAP. Design: Thirty-one consecutive OSAHS patients filled out the subjective ESS before nCPAP treatment (Pre-ESS). After a mean of about 10 months of nCPAP treatment, the patients filled out the ESS again, which was designated as the Post-ESS. Then they were asked to complete the scale again, recalling sleepiness before nCPAP treatment (Response Shift-Pre-ESS). The control group consisted of 11 patients with OSAHS who had not yet received nCPAP treatments and were matched for age, body mass index, and respiratory disturbance index. status. 18 This response shift before and after nCPAP treatment might explain why self-report measures underestimate the severity of sleepiness in the setting of chronic hypersomnolence that is recognized in OSAHS patients.
Setting
Engleman et al 19 reported that values of the ESS changed significantly between presentation and after nCPAP therapy of 22 weeks duration. Although data in that report actually demonstrated a response shift with regard to ESS changes before and after nCPAP treatment, the authors did not explicitly state it as such. In addition, that study did not include a control group.
We hypothesized that there is a response shift in perceptions of pretreatment sleepiness before and after nCPAP treatment in patients with OSAHS. We evaluated the response shift in ESS scores in OSAHS patients before and after nCPAP.
METHODS

Subjects
The medical ethics committee at our institution reviewed and approved the study. All subjects provided written informed consent. Two groups of patients were studied: a response group who received nCPAP treatment and a control group who had not received such treatment.
Response-Shift Group
Subjects were 31 consecutive patients (28 men, 3 women) with OSAHS who were determined by polysomnography (n = 21) or night oximetry (n = 10) and clinical symptoms to be candidates for nCPAP treatment. 2 Airflow during polysomnography was measured by nasal and oral thermistors. All participants who underwent polysomnography had an apnea-hypopnea index of 20 or greater. Ten patients with night oximetry had a 4% desaturation index of 40 or greater. The respiratory disturbance index (RDI) was defined as (1) the number of apnea plus hypopnea episodes per hour of sleep that resulted in more than 4% oxygen desaturation (SaO 2 ) compared to the basal SaO 2 before apnea or hypopnea and (2) the number of desaturation (> 4%) events per hour.
Control Group
The control group consisted of 11 age-, body mass index (BMI)-, and RDI-matched patients with OSAHS who had not yet received nCPAP treatment.
Sleepiness
With the ESS, subjects score themselves on a scale of 0 (not at all likely to fall asleep) to 3 (very likely to fall asleep) according to how easily they would fall asleep in 8 different situations, with possible overall scores of 0 to 24. The higher the score, the sleepier the individual. A score of 11 or higher is considered to represent an abnormal degree of daytime sleepiness. 9
Design
Response-Shift Group
All patients in the response-shift group filled out the ESS before nCPAP treatment (Pre-ESS) without input from family or friends. After more than 1 month of nCPAP treatment, they filled out the ESS again, which was designated as the Post-ESS. Finally, the patient filled out the ESS again by responding to the items through recall of sleepiness before nCPAP treatment (Response Shift-Pre-ESS). The subjects completed the ESS at each time point in the hospital.
Control Group
The 11 patients in the control group filled out the ESS twice at more than 1-month intervals before nCPAP treatment. The ESS was part of a standard clinical protocol. The participants remained blinded to the hypothesis of the study.
Statistical Analysis
Data are presented as 95% confidence intervals (95% CI). The data were tested by nonparametric methods because the distribution of the data was widely scattered. The Mann-Whitney U test was used to compare the results between the patients in the response-shift group and the control group. Differences between 2 conditions were tested for significance by the Wilcoxon signed-rank test. Differences between values obtained for more than 3 conditions were tested for significance by the Friedman test. If there was a significant difference by the Friedman test, intergroup differences were evaluated with the Wilcoxon signed-rank test. Spearman rank correlation coefficients were calculated to analyze the correlation between variables. A P value of < .05 was considered to be significant.
RESULTS
Response-Shift Group
Age and BMI in the 31 consecutive OSAHS patients were 48 years (95% CI, 44-52) and 30 kg/m 2 (95% CI, 28-31), respectively. No patient dropped out or failed to complete the ESS a second time. Clinical characteristics of the response-shift group are shown in Table 1 , and their Pre-ESS, Response-Shift-Pre-ESS and Post-ESS scores are shown in Figure 1 . Post-ESS and Response-Shift-Pre-ESS were taken after a mean of 299 days (range, 200-396 days) of nCPAP treatment. There was a significant response shift in ESS scores before and after nCPAP treatment (Pre-ESS: 8.5 [95% CI, 7.1-9.9] vs Response-Shift-Pre-ESS: 11.1 [95% CI, 9.5-12.8], P < .002) (Figure 1 ). Their measured compliance with CPAP, using a built-in clock, was 4.2 hours (range, 3.4-5.0 hours) per day. More patients initially underrated (68%) than overrated (19%) sleepiness as assessed by the ESS (P < .02) (Figure 2 ). For example, 8 patients had an ESS score of 11 or more before treatment, whereas 18 had such a score after nCPAP treatment.
Changes in RDI or the severity of desaturation during sleep before or after nCPAP treatment were not correlated with the degree of the response shift in ESS before and after nCPAP treatment. The degree of difference in the response shift in ESS before and after nCPAP treatment was not correlated with the duration of nCPAP use. 
Control Group
DISCUSSION
In this study, we found that the perceived sleepiness (ESS score) that was determined before nCPAP treatment changed significantly after treatment, as evaluated by ESS scores before and after nCPAP treatment. This represents a "response shift" such as has been described by Schwartz et al. 13 The diagnosis of OSAHS is dependent not only on the apnea hypopnea index, but also on clinical symptoms, of which daytime sleepiness is the most important. 6 Therefore, it is important to determine whether a response shift exists with OSAHS patients before and after treatment.
Engleman et al 19 cited "underreporting of sleepiness and driving impairment in patients with sleep apnoea/hypopnoea syndrome." In that report, ESS scores of 99 patients with OSAHS were obtained, first at presentation and then after treatment with nCPAP therapy of a median of 22 weeks' duration. Therefore, differences in the duration between the 2 measurements in our report and theirs exist (22 weeks vs 10 months). However, in both studies, more patients initially underestimated than overestimated sleepiness; 67% versus 29% (P < .001) cited by Engleman et al, and 68% and 19% reported here. Although Engleman et al did not mention the response-shift phenomenon as such, we are convinced that this phenomenon played a role in our results that showed differences in the subjects' perception of sleepiness before and after nCPAP treatment. Recently, the fundamental importance of the "response-shift" phenomenon has been recognized in social and medical science. Therefore, the presence of this phenomenon should be considered in evaluating sleepiness and health-related QOL for patients with OSAHS before and after nCPAP treatment.
Although there is a significant relationship between sleepiness and the RDI, sleepiness as rated by the ESS score varies widely. 14, 20 There have been many reports on the correlation between the subjective ESS scores and MSLT scores, which is thought to be an objective measure of sleepiness. It has been reported that most correlations were only slightly statistically significant. 10 However, in 1 report, no statistically or clinically significant association was seen between ESS scores and scores of the MSLT. 11 It has been interpreted that the subjective ESS and the objective MSLT may evaluate different complementary aspects of sleepiness. 11 Since a response shift was recognized before and after nCPAP treatment, the relationships between the ESS scores, including the response shift and the MSLT, may change. A further study should evaluate the relationships between ESS scores after the response shift and the MSLT scores.
Our study did not reveal a mechanism for the response shift in patients with OSAHS. For example, because there was no significant correlation between parameters during sleep and the size of the response shift in the ESS scores, we could not conclude that the response shifts were due to factors related to the degree of apnea and hypopnea during sleep. Neither could we conclude that the duration of nCPAP usage influenced the degree of the response-shift change.
It has been reported that, in the laboratory, driving-performance skills are markedly impaired in more than half of patients with OSAHS; in fact, in George et al's study, 15 more than half of patients with severe OSAHS performed worse than subjects without OSAHS who drank moderate amounts of alcohol. Therefore, at least half of patients with severe OSAHS may underestimate their degree of sleepiness before treatment, and a response shift would become apparent upon reevaluation of daytime sleepiness in such patients. In addition, recently it was reported that chronic restriction of sleep to 4 hours or 6 hours per night over 14 consecutive days resulted in significant, cumulative, dosedependent deficits in cognitive performance on all tasks. 21 It was also shown that the subjective sleepiness rating showed an acute response to sleep restriction but only small further increases on subsequent days and did not significantly differentiate between the 6-hour and 4-hour conditions. 21 Thus, partial sleep deprivation following recurrent sleep apnea and hypopnea would dampen subjective perceptions of sleepiness. Magnetic resonance imaging studies of the brain have shown diminished regional and often unilateral gray matter loss in multiple sites of the brain in patients with OSAHS. 22 Such damage in OSAHS patients might also affect subjective perceptions of sleepiness. Further studies are needed to investigate the mechanism that links response shifts and subjective perceptions of sleepiness.
In this study, the mean duration between Post-ESS and Response- Shift-Pre-ESS was 10 months. In Japan, patients who use nCPAP under health insurance must come to the hospital every month. We obtained the first ESS before nCPAP treatment at the first consultation day. We performed our study in 31 consecutive patients after more than 1 month of nCPAP therapy, and their mean duration of nCPAP treatment was 299 days (95% CI, 200-396). It has been reported that there was a significant fall in the mean ESS score from before nCPAP treatment to 2 months after treatment. 23 Hardinge et al's report noted that the duration of nCPAP treatment that could result in a decrease in ESS scores to a level usually seen in normal subjects was not 9 months but 12 months. 23 Therefore, a mean duration of 10 months of nCPAP treatment would be acceptable. The duration of nCPAP treatment for our controls was 50 (95% CI, 31-69) days. It was felt inappropriate to withhold active treatment for a longer period, and the ESS scores did not change significantly from the first and second testing. Since ESS scores have been said to not change significantly over several months under circumstances when daytime sleepiness was expected to remain constant, 24 the difference in the duration between the response-shift and control groups would not have significant effects on the results of this study. Test-retest reliability has been proven in the ESS 24 and other psychometric properties 25 in OSAHS patients before nCPAP treatment. Therefore, it can be considered that the changes in the ESS in this report were due to the responseshift phenomenon.
Based on the results of this study, the response shift after nCPAP treatment should be taken into consideration when deciding whether patients with OSAHS should be treated according to their sleepiness. We should recognize that perceptions of the degree of sleepiness prior to treatment might change when patients with OSAHS are asked to recall the degree of their pretreatment sleepiness after they have been treated with nCPAP.
